Zoetis is a global leader in animal health, providing a diverse range of products and services that include vaccines, medicines, diagnostic products, genetic tests, and biodevices. The company's strong focus on innovation and research has allowed it to develop a robust portfolio addressing various animal health needs. Zoetis benefits from an extensive distribution network and strong customer relationships, particularly with veterinarians and livestock producers. However, the company faces challenges such as regulatory hurdles, competition from other animal health companies, and the need for continuous innovation. As the demand for animal healthcare continues to grow, driven by increasing pet ownership and the need for sustainable livestock production, Zoetis is well-positioned to capitalize on these trends. Nevertheless, it must navigate potential risks, including market volatility and changes in regulatory environments.